Table 1.
New pricing mechanisms introduced on 1 June 2015 (13)
| Group of products | New pricing mechanism |
|---|---|
| Drugs included in the HIF with existing market competition1 | Reimbursement standard |
| Drugs included in the HIF with little or no market competition | Multilateral negotiations |
| (i.e. in-patent drugs, exclusively produced traditional Chinese medicines)1 | |
| Blood products and drugs procured and subsidised by the government | Tenders or multilateral negotiations |
| (i.e. vaccines, HIV/AIDS drugs, contraceptives)1,2 |
HIF: Health Insurance Formulary.
1
Except Class I psychotropics and anaesthetics, which remained under the government guided pricing.
2
Applies to blood products not included in the HIF.